Germany · Delayed Price · Currency is EUR Intra-Cellular Therapies Statistics
Total Valuation
PCCW Limited has a market cap or net worth of EUR 4.79 billion. The enterprise value is 11.43 billion.
| Market Cap | 4.79B |
| Enterprise Value | 11.43B |
Important Dates
The last earnings date was Wednesday, July 23, 2025.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | May 19, 2025 |
Share Statistics
| Current Share Class | 7.73B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.01B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| PB Ratio | 5.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -369.57 |
| EV / Sales | 2.67 |
| EV / EBITDA | 15.00 |
| EV / EBIT | 19.05 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 8.01.
| Current Ratio | 0.70 |
| Quick Ratio | 0.34 |
| Debt / Equity | 8.01 |
| Debt / EBITDA | 8.23 |
| Debt / FCF | n/a |
| Interest Coverage | 2.36 |
Financial Efficiency
Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 5.45%.
| Return on Equity (ROE) | 33.38% |
| Return on Assets (ROA) | 3.63% |
| Return on Invested Capital (ROIC) | 5.45% |
| Return on Capital Employed (ROCE) | 7.31% |
| Revenue Per Employee | 288,127 |
| Profits Per Employee | -2,117 |
| Employee Count | 14,600 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 9.22 |
Taxes
In the past 12 months, PCCW Limited has paid 104.89 million in taxes.
| Income Tax | 104.89M |
| Effective Tax Rate | 29.17% |
Stock Price Statistics
The stock price has increased by +34.41% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +34.41% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 57.55 |
| Average Volume (20 Days) | 2,315 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PCCW Limited had revenue of EUR 4.21 billion and -30.91 million in losses. Loss per share was -0.00.
| Revenue | 4.21B |
| Gross Profit | 2.02B |
| Operating Income | 621.76M |
| Pretax Income | 359.58M |
| Net Income | -30.91M |
| EBITDA | 707.73M |
| EBIT | 621.76M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 252.63 million in cash and 6.43 billion in debt, giving a net cash position of -6.17 billion.
| Cash & Cash Equivalents | 252.63M |
| Total Debt | 6.43B |
| Net Cash | -6.17B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 802.26M |
| Book Value Per Share | 0.08 |
| Working Capital | -742.38M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 48.00%, with operating and profit margins of 14.78% and -0.13%.
| Gross Margin | 48.00% |
| Operating Margin | 14.78% |
| Pretax Margin | 8.55% |
| Profit Margin | -0.13% |
| EBITDA Margin | 16.82% |
| EBIT Margin | 14.78% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 5.23%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 5.23% |
| Dividend Growth (YoY) | -27.45% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.05% |
| Shareholder Yield | 5.19% |
| Earnings Yield | -0.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |